| scholarly article | Q13442814 |
| P50 | author | Amy T Hutchison | Q85679191 |
| Robert E Steinert | Q43147373 | ||
| Radhika V Seimon | Q57364712 | ||
| Natalie D Luscombe-Marsh | Q61822999 | ||
| P2093 | author name string | Christine Feinle-Bisset | |
| Kylie Lange | |||
| Michael Horowitz | |||
| Gudrun Schober | |||
| Maria F Landrock | |||
| P2860 | cites work | Critical role for peptide YY in protein-mediated satiation and body-weight regulation | Q28261574 |
| Ghrelin induces adiposity in rodents | Q29619226 | ||
| Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. | Q31016826 | ||
| Meta-analysis of individual participant data: rationale, conduct, and reporting | Q33530020 | ||
| Pooled-data analysis identifies pyloric pressures and plasma cholecystokinin concentrations as major determinants of acute energy intake in healthy, lean men. | Q33581845 | ||
| Food intake and the regulation of body weight. | Q33883882 | ||
| A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans | Q34085069 | ||
| Effect of peptide YY3-36 on food intake in humans | Q34467196 | ||
| Management of obesity | Q34513665 | ||
| Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy | Q35118214 | ||
| Physical state of meal affects gastric emptying, cholecystokinin release and satiety | Q77349393 | ||
| Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men | Q82965210 | ||
| Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men | Q84068048 | ||
| Intraduodenal protein modulates antropyloroduodenal motility, hormone release, glycemia, appetite, and energy intake in lean men | Q84703398 | ||
| Effects of intraduodenal infusion of the branched-chain amino acid leucine on ad libitum eating, gut motor and hormone functions, and glycemia in healthy men | Q85932911 | ||
| Effects of intraduodenal infusion of L-tryptophan on ad libitum eating, antropyloroduodenal motility, glycemia, insulinemia, and gut peptide secretion in healthy men | Q88074605 | ||
| Gastrointestinal regulation of food intake | Q35251043 | ||
| The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans | Q35359964 | ||
| Protein, amino acids and the control of food intake | Q35895525 | ||
| Dietary protein, weight loss, and weight maintenance | Q37463187 | ||
| Digestive physiology of the pig symposium: secretion of gastrointestinal hormones and eating control | Q38073233 | ||
| Intestinal GLP-1 and satiation: from man to rodents and back | Q38575560 | ||
| Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes | Q41585674 | ||
| Calculating correlation coefficients with repeated observations: Part 1--Correlation within subjects | Q41972849 | ||
| A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis | Q43300856 | ||
| Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men | Q43518717 | ||
| Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans | Q43541711 | ||
| Ghrelin Enhances Appetite and Increases Food Intake in Humans | Q43819888 | ||
| Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men. | Q44105567 | ||
| Interaction between GLP-1 and CCK-33 in inhibiting food intake and appetite in men. | Q44856570 | ||
| Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length | Q44912774 | ||
| Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean men. | Q44928940 | ||
| Effects of varying combinations of intraduodenal lipid and carbohydrate on antropyloroduodenal motility, hormone release, and appetite in healthy males | Q46124623 | ||
| Reproducibility of energy intake, gastric emptying, blood glucose, plasma insulin and cholecystokinin responses in healthy young males | Q46445547 | ||
| Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and women | Q46457261 | ||
| Effect of small intestinal glucose load on plasma ghrelin in healthy men. | Q46542586 | ||
| Dose-related effects of lauric acid on antropyloroduodenal motility, gastrointestinal hormone release, appetite, and energy intake in healthy men. | Q46551460 | ||
| Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide | Q46627688 | ||
| Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes | Q46990563 | ||
| The droplet size of intraduodenal fat emulsions influences antropyloroduodenal motility, hormone release, and appetite in healthy males. | Q47187990 | ||
| A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations | Q47375814 | ||
| Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects | Q48189009 | ||
| Relation between food intake and visual analogue scale ratings of appetite and other sensations in healthy older and young subjects | Q48561729 | ||
| Effects of duodenal nutrients on sensory and motor responses of the human stomach to distension | Q48738233 | ||
| Effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age | Q48741354 | ||
| The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger | Q48984819 | ||
| Topography and measurement of pyloric pressure waves and tone in humans | Q51624344 | ||
| Satiety related to 24 h diet-induced thermogenesis during high protein/carbohydrate vs high fat diets measured in a respiration chamber | Q52896312 | ||
| Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women | Q52914829 | ||
| The effects of a high-carbohydrate, high-protein or balanced lunch upon later food intake and hunger ratings. | Q55033234 | ||
| Effects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men | Q58447635 | ||
| Comparative effects of intraduodenal infusions of lauric and oleic acids on antropyloroduodenal motility, plasma cholecystokinin and peptide YY, appetite, and energy intake in healthy men | Q59234938 | ||
| Effects of lauric acid on upper gut motility, plasma cholecystokinin and peptide YY, and energy intake are load, but not concentration, dependent in humans | Q59235050 | ||
| Low-dose pancreatic polypeptide inhibits food intake in man | Q61068502 | ||
| Load-dependent effects of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men | Q62209928 | ||
| Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men | Q62479378 | ||
| Antropyloroduodenal motor responses to intraduodenal lipid infusion in healthy volunteers | Q68339995 | ||
| Motor mechanisms associated with slowing of the gastric emptying of a solid meal by an intraduodenal lipid infusion | Q69169662 | ||
| Effect of glucose supplementation on appetite and the pyloric motor response to intraduodenal glucose and lipid | Q74518338 | ||
| P433 | issue | 17 | |
| P921 | main subject | data analysis | Q1988917 |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Physiological Reports | Q15716763 |
| P1476 | title | Contributions of upper gut hormones and motility to the energy intake-suppressant effects of intraduodenal nutrients in healthy, lean men - a pooled-data analysis | |
| P478 | volume | 4 |
| Q92611144 | Effects of Intraduodenal Infusion of the Bitter Tastant, Quinine, on Antropyloroduodenal Motility, Plasma Cholecystokinin, and Energy Intake in Healthy Men |
| Q92636407 | Gastrointestinal Sensing of Meal-Related Signals in Humans, and Dysregulations in Eating-Related Disorders |
| Q61805569 | Intraduodenal Administration of L-Valine Has No Effect on Antropyloroduodenal Pressures, Plasma Cholecystokinin Concentrations or Energy Intake in Healthy, Lean Men |
Search more.